AGM
Federal Agricultural Mortgage Corporation
AGM has a slight edge over JPM overall, supported by stronger valuation and stronger modeled upside.
JPM
JPMorgan Chase & Co.
JPM has slightly lower modeled downside risk, despite its lower overall score.
AGM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
AGM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like AGM.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
AGM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 8x | $175 | — |
| Cheap | 9x | $169 | -3.4% |
| Current | 9.3x | $175 | — |
| Fair | 11x | $198 | +13% |
| Expensive | 12x | $230 | +31% |
Historical ranges are pointers, not guarantees.
AGM's PE is in its cheap range at 9.3x. If earnings grow as analysts expect, today's price would be 8.0x next year's earnings.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM has the edge over AGM in the historical PE scenario, which offers more potential upside but is not a forecast.
AGM Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
AGM has the edge over JPM on the outlook, with more favorable valuation expectations.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
AGM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $21.78 | +15% |
| Q3 2026 | $18.88 | +7.6% |
| Q2 2026 | $18.29 | +7.8% |
| Q1 2026 | $17.36 | +7.4% |
| Q4 2025 | $16.62 | +1.1% |
| Q3 2025 | $17.55 | +13% |
| Q2 2025 | $16.97 | +3.6% |
| Q1 2025 | $16.17 | -1.4% |
| Q4 2024 | $16.44 | +4% |
AGM earned $18.88 per share over the past year, up 7.6% from the year before.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over AGM on earnings, with more consistent year-over-year improvement.
AGM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $125.3M | +20% |
| Q2 2026 | $125M | +22% |
| Q1 2026 | $109.1M | +16% |
| Q4 2025 | $107.5M | +6.1% |
| Q3 2025 | $104M | +15% |
| Q2 2025 | $102.6M | +14% |
| Q1 2025 | $94.3M | +0.7% |
| Q4 2024 | $101.3M | +19% |
AGM has the edge over JPM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 64% | -0.6 points |
| Q2 2026 | 65% | +1.7 points |
| Q1 2026 | 65% | -1.5 points |
| Q4 2025 | 56% | -11 points |
| Q3 2025 | 64% | -4.7 points |
| Q2 2025 | 64% | -2.2 points |
| Q1 2025 | 67% | -5.9 points |
| Q4 2024 | 68% | -3.6 points |
AGM has the edge over JPM on profitability, with a higher operating margin.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM's operating margin was 40% last quarter, about level with the same quarter a year ago.
AGM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $362.7M | +389% |
| Q2 2026 | $40.4M | +$88.1M |
| Q1 2026 | $92.1M | +$141.9M |
| Q4 2025 | $103.4M | -72% |
| Q3 2025 | $74.2M | +$118.6M |
| Q2 2025 | -$47.7M | -191% |
| Q1 2025 | -$49.8M | -122% |
| Q4 2024 | $367.5M | +$534.4M |
AGM has the edge over JPM on cash generation, producing positive trailing cash flow while its opponent burns cash.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM's free cash flow was −$84.2B over the past year, against −$120B the year before. Free cash flow isn't a meaningful measure for financial services companies like JPM.
AGM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +27K shares |
| 1 year | -0.6% | -63K shares |
| 3 years | -0.3% | -29K shares |
| 5 years | +0.6% | +67K shares |
| Available history | +1.2% | +131K shares |
AGM has 11M diluted shares, down 0.6% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $7.1M |
| Q4 2021 | — |
| Q3 2021 | — |
| Q2 2021 | — |
| Q1 2021 | — |
| Q4 2020 | — |
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over AGM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
AGM Net Leverage
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
AGM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.8 | Neutral |
| Stochastic | 8.2 | Oversold |
AGM's weekly RSI is 35 (neutral) and its Stochastic is 8 (oversold).
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
AGM PE vs Financial Services Sector
| Metric | AGM | Sector median | Relative |
|---|---|---|---|
| PE | 9.3x | 13x | 29% below |
| PE % | 23 | 63 | 40 pts below |
AGM has the edge over JPM on valuation relative to its sector.
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
AGM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $199.2 | 12% below |
| 20 week MA | $211.2 | 17% below |
| 50 week MA | $186.6 | 6.1% below |
| 100 week MA | $185.7 | 5.6% below |
| 200 week MA | $177.6 | 1.3% below |
AGM is in a downtrend: it's below all five of its weekly moving averages, and 1.3% below its 200-week average.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has the edge over AGM on trend strength, trading above more of its moving averages.
AGM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $84.2 | $73.9 | -12% |
| 2021 | $73.9 | $120.7 | +63% |
| 2022 | $120.7 | $114.0 | -5.5% |
| 2023 | $114.0 | $191.2 | +68% |
| 2024 | $191.2 | $197.3 | +3.2% |
| 2025 | $197.3 | $177.6 | -10% |
| 2026 YTD | $177.6 | $175.2 | -1.3% |
AGM has finished lower in three of the last six years. It's down 1.3% so far in 2026.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over AGM on returns for 2026, with the stronger performance.